Find similar content

Source channel @githubtrending · Post #15340 · Dec 17

#python#gym#gym_environment#reinforcement_learning#reinforcement_learning_agent#reinforcement_learning_environments#rl_environment#rl_training NeMo Gym helps you build and run reinforcement‑learning training environments for large language models, letting you develop, test, and collect verified rollouts separately from the training loop and integrate with your preferred RL framework and model endpoints (OpenAI, vLLM, etc.). It includes ready resource servers, datasets, and patterns for multi‑step, multi‑turn, and tool‑using scenarios, runs on a typical dev machine (no GPU required), and is early-stage with evolving APIs and docs. Benefit: you can generate high‑quality, verifiable training data faster and plug it into existing training pipelines to improve model behavior. https://github.com/NVIDIA-NeMo/Gym

Hashtags

#python #gym #gym_environment #reinforcement_learning #reinforcement_learning_agent #reinforcement_learning_environments #rl_environment #rl_training

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment